Evidence map›Paper›PMID 31209184›Full record

ArticleAging2019

Alda-1 attenuates hyperoxia-induced mitochondrial dysfunction in lung vascular endothelial cells.

Sahebgowda Sidramagowda Patil, Helena Hernández-Cuervo, Jutaro Fukumoto, Venkata Ramireddy Narala, Smita Saji, Monica Borra, Matthew Alleyn, Muling Lin, Ramani Soundararajan, Richard Lockey and 2 more

Abstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Metabolites · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Alda-1 ameliorates air embolism-induced acute lung injury.International journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sahebgowda Sidramagowda PatilUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Helena Hernández-CuervoUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Jutaro FukumotoUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Venkata Ramireddy NaralaDepartment of Zoology, Yogi Vemana University, Kadapa, India.
Smita SajiUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Monica BorraUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Matthew AlleynUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Muling LinUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Ramani SoundararajanUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Richard LockeyUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Narasaiah KolliputiUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.
Lakshmi GalamUniversity of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, Florida 33612, United States.

Funding

Molecular Mechanisms of Hyperoxic Lung InjuryR01HL105932 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI KOLLIPUTI, NARASAIAH · 2011 to 2019
$2.9M
NHLBI NIH HHS R01 HL105932
6 · The paper itself

Abstract

Acute lung injury (ALI) is a major cause of morbidity and mortality worldwide, especially in aged populations. Mitochondrial damage is one of the key features of ALI. Hyperoxia-induced lung injury model in mice has been widely used for ALI study because it features many ALI phenotypes including, but not limited to, mitochondrial and vascular endothelial cell damage. Recently, accumulating evidence has shown that mitochondrial aldehyde dehydrogenase 2 (ALDH2) has a protective effect against oxidative stress mediated cell damage in epithelial cells. However, it is not known whether ALDH2 protects against oxidative stress in vascular endothelial cells. In this current study, we attempted to find the capacity of Alda-1 [(N-(1,3benzodioxol-5-ylmethyl)-2,6- dichloro-benzamide), an ALDH2 activator] to protect against oxidative stress in human microvascular endothelial cells (HMVEC). HMVEC pretreated with Alda-1 prior to hyperoxic exposure vs non-treated controls showed i) lower 4-hydroxynonenal (4-HNE) levels, ii) significantly decreased expressions of Bax and Cytochrome C, iii) partially restored activity and expression of ALDH2 and iv) significantly improved mitochondrial membrane potential. These results suggest that ALDH2 protein in lung vascular endothelial cells is a promising therapeutic target for the treatment of ALI and that Alda-1 is a potential treatment option.

Indexed as

Acute Lung InjuryAldehyde Dehydrogenase, MitochondrialBenzamidesBenzodioxolesEndothelial CellsGene Expression RegulationHumansHyperoxiaMicrovesselsMitochondriaOxidative StressOxygenAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanBenzamidesBenzodioxolesN-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamideOxygenacute lung injuryAlda-1ALDH2HMVEChyperoxia

Identifiers

PMID31209184
PMCPMC6628993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.